Mutations in the Human Gonadotropin-Releasing Hormone Receptor: Insights into Receptor Biology and Function

ABSTRACT

Pulsatile hypothalamic release of GnRH tightly controls reproduction by activating a specific cell membrane receptor (GnRHR) on the surface of pituitary gonadotrophs to stimulate luteinizing hormone and follicle-stimulating hormone secretion. During the last 10 years, 21 loss-of-function GNRHR mutations have been identified in patients with idiopathic hypogonadotropic hypogonadism. Although most patients with hypogonadotropic hypogonadism can be treated by delivery of exogenous pulsatile GnRH, in several cases, patients with GNRHR mutations fail to respond efficiently to GnRH treatment. The impact of each mutation on GnRHR function has been studied extensively in vitro, but correlation with clinical phenotype is not always evident. By combining recent advances into the molecular mechanisms controlling ligand binding and receptor activation with data accumulated from clinical studies, this review summarizes the overall structure-function relationships of the human GnRH receptor, with an emphasis on the impact of naturally occurring mutations. Furthermore, given that it was recently demonstrated that pharmacological chaperones can rescue altered receptor function in vitro, potential therapeutic approaches are also discussed.

KEYWORDS

Gonadotropin-releasing hormone - gonadotropin-releasing hormone receptor - luteinizing hormone - follicle-stimulating hormone - hypogonadotropic hypogonadism - mutations

REFERENCES

• 1 Levine J E, Ramirez V D. Luteinizing hormone-releasing hormone release during the rat estrous cycle and after ovariectomy, as estimated with push-pull cannulae.  Endocrinology. 1982;  111 1439-1448
• 2 Santoro N, Filicori M, Spratt D, Crowley Jr W F. Gonadotropin-releasing hormone (GnRH) physiology in men and women.  Acta Med Hung. 1986;  43 201-221
• 3 Dalkin A C, Haisenleder D J, Ortolano G A, Ellis T R, Marshall J C. The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression.  Endocrinology. 1989;  125 917-924
• 4 Kaiser U B, Jakubowiak A, Steinberger A, Chin W W. Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro.  Endocrinology. 1997;  138 1224-1231
• 5 Bedecarrats G Y, Kaiser U B. Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration.  Endocrinology. 2003;  144 1802-1811
• 6 Burger L L, Haisenleder D J, Dalkin A C, Marshall J C. Regulation of gonadotropin subunit gene transcription.  J Mol Endocrinol. 2004;  33 559-584
• 7 Naor Z, Jabbour H N, Naidich M et al.. Reciprocal cross talk between gonadotropin-releasing hormone (GnRH) and prostaglandin receptors regulates GnRH receptor expression and differential gonadotropin secretion.  Mol Endocrinol. 2007;  21 524-537
• 8 Kaiser U B, Sabbagh E, Katzenellenbogen R A, Conn P M, Chin W W. A mechanism for the differential regulation of gonadotropin subunit gene expression by gonadotropin-releasing hormone.  Proc Natl Acad Sci USA. 1995;  92 12280-12284
• 9 Franco B, Guioli S, Pragliola A et al.. A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules.  Nature. 1991;  353 529-536
• 10 Legouis R, Hardelin J P, Levilliers J et al.. The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules.  Cell. 1991;  67 423-435
• 11 Seminara S B, Messager S, Chatzidaki E E et al.. The GPR54 gene as a regulator of puberty.  N Engl J Med. 2003;  349 1614-1627
• 12 De Roux N, Genin E, Carel J, Matsuda F, Chaussain J, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.  Proc Natl Acad Sci USA. 2003;  100 10972-10976
• 13 Dode C, Levilliers J, Dupont J et al.. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome.  Nat Genet. 2003;  33 463-465
• 14 Tsai P S, Gill J C. Mechanisms of disease: insights into X-linked and autosomal-dominant Kallmann syndrome.  Nat Clin Pract Endocrinol Metab. 2006;  2 160-171
• 15 Iovane A, Aumas C, De Roux N. New insights in the genetics of isolated hypogonadotropic hypogonadism.  Eur J Endocrinol. 2004;  151(suppl 3) U83-U88
• 16 Layman L C, Cohen D P, Jin M et al.. Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism.  Nat Genet. 1998;  18 14-15
• 17 De Roux N, Young J, Misrahi M et al.. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor.  N Engl J Med. 1997;  337 1597-1602
• 18 Karges B, Karges W, De Roux N. Clinical and molecular genetics of the human GnRH receptor.  Hum Reprod Update. 2003;  9 523-530
• 19 Layman L C. Genetic causes of human infertility.  Endocrinol Metab Clin North Am. 2003;  32 549-572
• 20 Millar R P, Lu Z L, Pawson A J, Flanagan C A, Morgan K, Maudsley S R. Gonadotropin-releasing hormone receptors.  Endocr Rev. 2004;  25 235-275
• 21 Neill J D, Musgrove L C, Duck L W. Newly recognized GnRH receptors: function and relative role.  Trends Endocrinol Metab. 2004;  15 383-392
• 22 Chang C K, Leung P C. Molecular biology of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans.  Endocr Rev. 2005;  26 283-306
• 23 Ballesteros J, Kitanovic S, Guarnieri F et al.. Functional microdomains in G-protein-coupled receptors. The conserved arginine-cage motif in the gonadotropin-releasing hormone receptor.  J Biol Chem. 1998;  273 10445-10453
• 24 Hapgood J P, Sadie H, van Biljon W, Ronacher K. Regulation of expression of mammalian gonadotrophin-releasing hormone receptor genes.  J Neuroendocrinol. 2005;  17 619-638
• 25 Fan N C, Peng C, Krisinger J, Leung P C. The human gonadotropin-releasing hormone receptor gene: complete structure including multiple promoters, transcription initiation sites, and polyadenylation signals.  Mol Cell Endocrinol. 1995;  107 R1-R8
• 26 Kakar S S. Molecular structure of the human gonadotropin-releasing hormone receptor gene.  Eur J Endocrinol. 1997;  137 183-192
• 27 Albarracin C T, Kaiser U B, Chin W W. Isolation and characterization of the 5′-flanking region of the mouse gonadotropin-releasing hormone receptor gene.  Endocrinology. 1994;  135 2300-2306
• 28 Reinhart J, Xiao S, Arora K K, Catt K J. Structural organization and characterization of the promoter region of the rat gonadotropin-releasing hormone receptor gene.  Mol Cell Endocrinol. 1997;  130 1-12
• 29 Campion C E, Turzillo A M, Clay C M. The gene encoding the ovine gonadotropin-releasing hormone (GnRH) receptor: cloning and initial characterization.  Gene. 1996;  170 277-280
• 30 Zhou W, Sealfon S C. Structure of the mouse gonadotropin-releasing hormone receptor gene: variant transcripts generated by alternative processing.  DNA Cell Biol. 1994;  13 605-614
• 31 Grosse R, Schoneberg T, Schultz G, Gudermann T. Inhibition of gonadotropin-releasing hormone receptor signaling by expression of a splice variant of the human receptor.  Mol Endocrinol. 1997;  11 1305-1318
• 32 Wang L, Oh D Y, Bogerd J et al.. Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling.  Endocrinology. 2001;  142 4015-4025
• 33 Cheung T C, Hearn J P. Developmental expression and subcellular localization of wallaby gonadotropin-releasing hormone receptor and its splice variants.  Gen Comp Endocrinol. 2003;  133 88-99
• 34 Shimizu M, Bedecarrats G Y. Identification of a novel pituitary-specific chicken gonadotropin-releasing hormone receptor and its splice variants.  Biol Reprod. 2006;  75 800-808
• 35 Flanagan C A, Becker I I, Davidson J S et al.. Glutamate 301 of the mouse gonadotropin-releasing hormone receptor confers specificity for arginine 8 of mammalian gonadotropin-releasing hormone.  J Biol Chem. 1994;  269 22636-22641
• 36 Flanagan C A, Rodic V, Konvicka K et al.. Multiple interactions of the Asp(2.61(98)) side chain of the gonadotropin-releasing hormone receptor contribute differentially to ligand interaction.  Biochemistry. 2000;  39 8133-8141
• 37 Hoffmann S H, ter Laak T, Kuhne R, Reilander H, Beckers T. Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding.  Mol Endocrinol. 2000;  14 1099-1115
• 38 Davidson J S, Flanagan C A, Zhou W et al.. Identification of N-glycosylation sites in the gonadotropin-releasing hormone receptor: role in receptor expression but not ligand binding.  Mol Cell Endocrinol. 1995;  107 241-245
• 39 Davidson J S, McArdle C A, Davies P, Elario R, Flanagan C A, Millar R P. Asn102 of the gonadotropin-releasing hormone receptor is a critical determinant of potency for agonists containing C-terminal glycinamide.  J Biol Chem. 1996;  271 15510-15514
• 40 Söderhäll J A, Polymeropoulos E E, Paulini K, Gunther E, Kuhne R. Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor.  Biochem Biophys Res Commun. 2005;  333 568-582
• 41 Hovelmann S, Hoffmann S H, Kuhne R, ter Laak T, Reilander H, Beckers T. Impact of aromatic residues within transmembrane helix 6 of the human gonadotropin-releasing hormone receptor upon agonist and antagonist binding.  Biochemistry. 2002;  41 1129-1136
• 42 Fromme B J, Katz A A, Roeske R W, Millar R P, Flanagan C A. Role of aspartate7.32(302) of the human gonadotropin-releasing hormone receptor in stabilizing a high-affinity ligand conformation.  Mol Pharmacol. 2001;  60 1280-1287
• 43 Fromme B J, Katz A A, Millar R P, Flanagan C A. Pro7.33(303) of the human GnRH receptor regulates selective binding of mammalian GnRH.  Mol Cell Endocrinol. 2004;  219 47-59
• 44 Beranova M, Oliveira L M, Bedecarrats G Y et al.. Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism.  J Clin Endocrinol Metab. 2001;  86 1580-1588
• 45 Bhagavath B, Ozata M, Ozdemir I C et al.. The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism.  Fertil Steril. 2005;  84 951-957
• 46 Topaloglu A K, Lu Z L, Farooqi I S et al.. Molecular genetic analysis of normosmic hypogonadotropic hypogonadism in a Turkish population: identification and detailed functional characterization of a novel mutation in the gonadotropin-releasing hormone receptor gene.  Neuroendocrinology. 2006;  84 301-308
• 47 Cerrato F, Shagoury J, Kralickova M et al.. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism.  Eur J Endocrinol. 2006;  155(suppl 1) S3-S10
• 48 Bedecarrats G Y, Linher K D, Janovick J A et al.. Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function.  Mol Cell Endocrinol. 2003;  205 51-64
• 49 Maya-Nunez G, Janovick J A, Ulloa-Aguirre A, Soderlund D, Conn P M, Mendez J P. Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site.  J Clin Endocrinol Metab. 2002;  87 2144-2149
• 50 Assefa D, Pawson A J, McArdle C A et al.. A new photoreactive antagonist cross-links to the N-terminal domain of the gonadotropin-releasing hormone receptor.  Mol Cell Endocrinol. 1999;  156 179-188
• 51 Karges B, Karges W, Mine M et al.. Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism.  J Clin Endocrinol Metab. 2003;  88 1873-1879
• 52 Costa E M, Bedecarrats G Y, Mendonca B B, Arnhold I J, Kaiser U B, Latronico A C. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.  J Clin Endocrinol Metab. 2001;  86 2680-2686
• 53 Lu Z L, Gallagher R, Sellar R, Coetsee M, Millar R P. Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.  J Biol Chem. 2005;  280 29796-29803
• 54 Bédécarrats G Y, Linher K D, Kaiser U B. Two common naturally occurring mutations in the human gonadotropin-releasing hormone (GnRH) receptor have differential effects on gonadotropin gene expression and on GnRH-mediated signal transduction.  J Clin Endocrinol Metab. 2003;  88 834-843
• 55 Meysing A U, Kanasaki H, Bédécarrats G Y et al.. GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone.  J Clin Endocrinol Metab. 2004;  89 3189-3198
• 56 Caron P, Chauvin S, Christin-Maitre S et al.. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration.  J Clin Endocrinol Metab. 1999;  84 990-996
• 57 Pralong F P, Gomez F, Castillo E et al.. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor.  J Clin Endocrinol Metab. 1999;  84 3811-3816
• 58 De Roux N, Young J, Misrahi M, Schaison G, Milgrom E. Loss of function mutations of the GnRH receptor: a new cause of hypogonadotropic hypogonadism.  J Pediatr Endocrinol Metab. 1999;  12(suppl 1) 267-275
• 59 Kottler M L, Chauvin S, Lahlou N et al.. A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect.  J Clin Endocrinol Metab. 2000;  85 3002-3008
• 60 Thompson M D, Burnham W M, Cole D E. The G protein-coupled receptors: pharmacogenetics and disease.  Crit Rev Clin Lab Sci. 2005;  42 311-392
• 61 Conn P M, Leanos-Miranda A, Janovick J A. Protein origami: therapeutic rescue of misfolded gene products.  Mol Interv. 2002;  2 308-316
• 62 Conn P M, Knollman P E, Brothers S P, Janovick J A. Protein folding as post-translational regulation: Evolution of a mechanism for controlled plasma membrane expression of a GPCR.  Mol Endocrinol. 2006;  20 3035-3041
• 63 Knollman P E, Janovick J A, Brothers S P, Conn P M. Parallel regulation of membrane trafficking and dominant-negative effects by misrouted gonadotropin-releasing hormone receptor mutants.  J Biol Chem. 2005;  280 24506-24514
• 64 Arora K K, Chung H O, Catt K J. Influence of a species-specific extracellular amino acid on expression and function of the human gonadotropin-releasing hormone receptor.  Mol Endocrinol. 1999;  13 890-896
• 65 Maya-Nunez G, Janovick J A, Conn P M. Combined modification of intracellular and extracellular loci on human gonadotropin-releasing hormone receptor provides a mechanism for enhanced expression.  Endocrine. 2000;  13 401-407
• 66 Janovick J A, Knollman P E, Brothers S P, Ayala-Yanez R, Aziz A S, Conn P M. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.  J Biol Chem. 2006;  281 8417-8425
• 67 Hartl F U, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein.  Science. 2002;  295 1852-1858
• 68 Morello J P, Salahpour A, Laperriere A et al.. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.  J Clin Invest. 2000;  105 887-895
• 69 Ashton W T, Sisco R M, Yang Y T et al.. Potent nonpeptide GnRH receptor antagonists derived from substituted indole-5-carboxamides and -acetamides bearing a pyridine side-chain terminus.  Bioorg Med Chem Lett. 2001;  11 1727-1731
• 70 Janovick J A, Maya-Nunez G, Conn P M. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.  J Clin Endocrinol Metab. 2002;  87 3255-3262
• 71 Leanos-Miranda A, Janovick J A, Conn P M. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.  J Clin Endocrinol Metab. 2002;  87 4825-4828
• 72 Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors.  Endocr Rev. 2000;  21 90-113
• 73 Arnis S, Fahmy K, Hofmann K P, Sakmar T P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin.  J Biol Chem. 1994;  269 23879-23881
• 74 Cordeaux Y, Nickolls S A, Flood L A, Graber S G, Strange P G. Agonist regulation of D(2) dopamine receptor/G protein interaction. Evidence for agonist selection of G protein subtype.  J Biol Chem. 2001;  276 28667-28675
• 75 Kaiser U B, Conn P M, Chin W W. Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines.  Endocr Rev. 1997;  18 46-70
• 76 Stojilkovic S S, Reinhart J, Catt K J. Gonadotropin-releasing hormone receptors: structure and signal transduction pathways.  Endocr Rev. 1994;  15 462-499
• 77 McArdle C A, Franklin J, Green L, Hislop J N. Signalling, cycling and desensitisation of gonadotrophin-releasing hormone receptors.  J Endocrinol. 2002;  173 1-11
• 78 Dobkin-Bekman M, Naidich M, Pawson A J, Millar R P, Seger R, Naor Z. Activation of mitogen-activated protein kinase (MAPK) by GnRH is cell-context dependent.  Mol Cell Endocrinol. 2006;  252 184-190
• 79 Liu F, Usui I, Evans L G et al.. Involvement of both G(q/11) and G(s) proteins in gonadotropin-releasing hormone receptor-mediated signaling in L beta T2 cells.  J Biol Chem. 2002;  277 32099-32108
• 80 Grundker C, Volker P, Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase.  Endocrinology. 2001;  142 2369-2380
• 81 Pitteloud N, Boepple P A, DeCruz S, Valkenburgh S B, Crowley Jr W F, Hayes F J. The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptor.  J Clin Endocrinol Metab. 2001;  86 2470-2475
• 82 Lin L, Conway G S, Hill N R, Dattani M T, Hindmarsh P C, Achermann J C. A homozygous R262Q mutation in the gonadotropin-releasing hormone receptor presenting as constitutional delay of growth and puberty with subsequent borderline oligospermia.  J Clin Endocrinol Metab. 2006;  91 5117-5121
• 83 Seminara S B, Beranova M, Oliveira L M, Martin K A, Crowley Jr W F, Hall J E. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations.  J Clin Endocrinol Metab. 2000;  85 556-562
• 84 Dewailly D, Boucher A, Decanter C, Lagarde J P, Counis R, Kottler M L. Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor gene.  Fertil Steril. 2002;  77 1288-1291
• 85 De Roux N, Young J, Brailly-Tabard S, Misrahi M, Milgrom E, Schaison G. The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred.  J Clin Endocrinol Metab. 1999;  84 567-572
• 86 Pitteloud N, Quinton R, Pearce S et al.. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism.  J Clin Invest. 2007;  117 457-463
• 87 Soderlund D, Canto P, de la Chesnaye E, Ulloa-Aguirre A, Mendez J P. A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene.  Clin Endocrinol (Oxf). 2001;  54 493-498
• 88 Antelli A, Baldazzi L, Balsamo A et al.. Two novel GnRHR gene mutations in two siblings with hypogonadotropic hypogonadism.  Eur J Endocrinol. 2006;  155 201-205
• 89 Layman L C, Cohen D P, Xie J, Smith G D. Clinical phenotype and infertility treatment in a male with hypogonadotropic hypogonadism due to mutations Ala129Asp/Arg262Gln of the gonadotropin-releasing hormone receptor.  Fertil Steril. 2002;  78 1317-1320
• 90 Wolczynski S, Laudanski P, Jarzabek K, Mittre H, Lagarde J P, Kottler M L. A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene.  Fertil Steril. 2003;  79 442-444
• 91 Silveira L F, Stewart P M, Thomas M, Clark D A, Bouloux P M, MacColl G S. Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR “knockout”.  J Clin Endocrinol Metab. 2002;  87 2973-2977